ACKR1 and neoplasm: Accordingly, in a mouse model of prostate cancer, animals with a DARC-deficient background developed larger and more aggressive tumors with greater tumor associated neovascularization and increased intratumor levels of angiogenic ELR+ CXC chemokines [108].